Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators.

N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3.

2.

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I; SAVOR-TIMI 53 Steering Committee and Investigators.

N Engl J Med. 2013 Oct 3;369(14):1317-26. doi: 10.1056/NEJMoa1307684. Epub 2013 Sep 2.

3.

Admission serum potassium in patients with acute myocardial infarction: its correlates and value as a determinant of in-hospital outcome.

Madias JE, Shah B, Chintalapally G, Chalavarya G, Madias NE.

Chest. 2000 Oct;118(4):904-13.

PMID:
11035655
4.
5.

Comparative pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol.

Garg DC, Jallad NS, Mishriki A, Chalavarya G, Kraml M, Fencik M, Weidler DJ.

J Clin Pharmacol. 1987 May-Jun;27(5):390-6.

PMID:
3693583
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk